Our landmarks of OncoPharm series returns to discuss JBR10, adjuvant cisplatin/vinorelbine in NSCLC.
JBR10: https://www.nejm.org/doi/pdf/10.1056/NEJMoa043623
JBR10 Update: https://pubmed.ncbi.nlm.nih.gov/19933915/
LACE meta-analysis: https://pubmed.ncbi.nlm.nih.gov/18506026/
